Biora Therapeutics (BIOR) Stock Price, News & Analysis

Company Overview

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Key Stats

• Today's Range: $0.13 to $0.14
• 50-Day Range: $0.11 to $0.17
• 52-Week Range: $0.15 to $7.90
• Volume: 1,186 shs
• Average Volume: 63,692 shs
• Market Capitalization: $633,220.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $23.00
• Consensus Rating: Buy

BIOR Stock Analysis - Frequently Asked Questions

How have BIOR shares performed this year?

Biora Therapeutics' stock was trading at $0.22 on January 1st, 2025. Since then, BIOR stock has decreased by 36.4% and is now trading at $0.14.
View the best growth stocks for 2025 here.

How were Biora Therapeutics' earnings last quarter?

Biora Therapeutics, Inc. (NASDAQ:BIOR) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($4.60) earnings per share for the quarter, beating analysts' consensus estimates of ($4.70) by $0.10. The firm had revenue of $0.18 million for the quarter, compared to analyst estimates of $11.10 million.

When did Biora Therapeutics' stock split?

Shares of Biora Therapeutics reverse split on the morning of Tuesday, January 3rd 2023. The 1-25 reverse split was announced on Tuesday, January 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Biora Therapeutics?

Shares of BIOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Biora Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Biora Therapeutics investors own include AMC Entertainment (AMC), Digital World Acquisition (DWAC), NIO (NIO), Meta Platforms (META), NVIDIA (NVDA), Bank of America (BAC) and Ford Motor (F).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 4/16/2025
• Next Earnings (Estimated): 4/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:BIOR
• CIK: 1580063
• Web: www.bioratherapeutics.com
• Phone: 833-727-2841
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $23.00
• High Stock Price Target: $23.00
• Low Stock Price Target: $23.00
• Potential Upside/Downside: +16,328.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($13.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-124,110,000.00
• Net Margins: N/A
• Pretax Margin: -4,005.83%
• Return on Equity: N/A
• Return on Assets: -332.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: $892,000.00
• Price / Sales: 0.71
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($36.43) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 4,523,000
• Free Float: 2,213,000
• Market Cap: $633,220.00
• Optionable: Optionable
• Beta: 1.12